Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4412  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (934 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
  Historical Vignette
   The Dawn of the ...
   Therapy Based on...
   Vascular Changes...
   Neuroinflammatio...
   The Chronic and ...
   Post-Traumatic E...
  Summarizing
   The Big Question...
   Where Do We Go f...
  Conclusion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed295    
    Printed5    
    Emailed0    
    PDF Downloaded62    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
NI FEATURE: JOURNEY THROUGH THE EONS - COMMENTARY
Year : 2020  |  Volume : 68  |  Issue : 3  |  Page : 534-539

Unsolved Problems of Brain Trauma


National Brain Research Centre, Manesar, Gurugram, Haryana, India

Date of Web Publication6-Jul-2020

Correspondence Address:
Prof. Prakash N Tandon
National Brain Research Centre, Nainwal Mode, Manesar, Gurugram - 122 051, Haryana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.288988

Rights and Permissions



How to cite this article:
Tandon PN. Unsolved Problems of Brain Trauma. Neurol India 2020;68:534-9

How to cite this URL:
Tandon PN. Unsolved Problems of Brain Trauma. Neurol India [serial online] 2020 [cited 2020 Sep 26];68:534-9. Available from: http://www.neurologyindia.com/text.asp?2020/68/3/534/288988





  Historical Vignette Top


Sir Graham Teasdale, an old friend of mine, whose name as a neurotraumatologist has been immortalized by his epoch making study universally associated with the Glasgow Coma Scale (GCS).[1] He is credited with the establishment of the European Brain Injury Consortium and the International Neurotrauma Society, apart from his major contribution to the field of neurotraumatology.[2] Even 40 years later, the evidence showcases the GCS has stood the test of time.[3] My own interest in the field of neurotraumatology dates back to the days with Prof. Kristiansen, my mentor, who was deeply concerned regarding the challenges faced as early as 1949.[4] However, in spite of all the efforts and recent advances, some of the basic issues regarding the management of severe head injuries (SHI) remain unsolved. The list of such problems is long and hence I chose to restrict myself to explore, “Why in spite of all researches—basic and clinical—there has been no or little improvement in the morbidity and mortality following “Severe Head Injury”? This problem remained a subject of study throughout my professional career and even much later. I am reminded of a thought provoking statement by Sir Graham “Nemo satis sapit: nobody knows enough alone.”[2] I would like to share some excerpts from the Sir Graham Teasdale oration, I had delivered at AIIMS Neurotrauma conference, New Delhi, 2018 and also the thoughts of renowned neurotraumatologists on the subject.[5],[6],[7],[8]

However, first-hand study of a large number of SHI patients brought these problems in sharp focus.[9] The results of this study published as a monograph attracted an annotation in Lancet—”The treatment of the SHI is clearly becoming less the province of the inactive master than it has been hitherto.”

One of the important lessons learnt was the need for early angiography and appropriate surgery rather than “patients, watch full expectancy” followed by multiple burr-holes (some called it wood-pecker surgery) if clinical deterioration (dilating pupil, deepening, unconsciousness, developing neurological deficit) set in. Following some such regimes, Jennett, Teasdale, Galbraith et al. (1977) reported the mortality of severe head injury to be 51%.[10] Even much higher mortality was reported for some specific subgroups like an acute subdural hematoma or intracerebral hematoma (80–90%)[11],[12],[13],[14] [Table 1].
Table 1: Mortality in severe head injury

Click here to view


Langfitt reiterated, but none of the (Currently Advocated) modalities have been demonstrated to be effective, alone or in combination with others, by the only acceptable criteria for success, namely, a reduction in mortality or morbidity compared to a comparable group of patients who did not receive the treatment.[15] Langfitt and Gennarelli (1982) wondered, “Can the outcome from head injury be improved.”[16]


  The Dawn of the New “Aggressive Therapy” Top


It was around the 1970s that a number of neurosurgeons experimented with new therapeutic regimes to lower the mortality of SHI (GCS = <8). This was called “Aggressive treatment” consisting of intubation, artificial ventilation, intracranial pressure monitoring, high doses of corticosteroids, barbiturates [17],[18],[19],[20] [Figure 1]. Thus, Gordan 1976 authoritatively advocated “There should be no discussion, however, about the necessity in cases of unconscious head injured patients, of the establishment of an artificial airway and controlled hyperventilation before any other measures, diagnostic or operative, are started.”[17]
Figure 1: SHI patient treated in ICU setup in the current era: Mechanical Ventilation, Sedation, Intracranial pressure monitoring

Click here to view


A large multicentric study was initiated in the USA to evaluate this regime. My friend John Jane from Charlottesville, Virginia, USA who was part of this study, during his visit with us reviewed our study on such patients who were not submitted to the so-called “aggressive study.” Results of our studies were compared and published.[21]

It revealed no significant difference in outcome except for a small group of such patients [Figure 2].
Figure 2: Mortality following SHI: Comparison of two series with radically different treatment protocols

Click here to view


The so-called “Aggressive” treatment failed to provide additional benefits compared to conventional management.

We reported data collected prospectively on 551 cases in Delhi and 822 cases in Charlottesville, Virginia, USA. There was no statistically different mortality rate at the two centers even though the management strategy was different. Somewhat modified “Aggressive” treatment was used in Charlottesville, while the patients at Delhi received none of it—no artificial ventilator, ICP monitoring, corticosteroids, or barbiturates.[21]

A more detailed review of the literature and analysis of a larger series of head-injured patients at our center published in 1986 confirmed these observations. Notwithstanding recent advances, mortality from SHI remained high. New “Aggressive” management strategies (described above) introduced by high expectations in end results.[22]

A number of papers from other centers expressed similar concerns. “But none of the (Currently Advocated) modalities have been demonstrated to be effective, alone or in combination with others, by the only acceptable criteria for success, namely, a reduction in mortality or morbidity compared to a comparable group of patients who did not receive the treatment.[23]

Although conclusive evidence from randomized trials are not available to assess the merits of “Aggressive” treatment as a whole, a survey of the recent literature suggest that reports not finding “Aggressive” treatment to be beneficial are more reliable in comparing series than are those that claim improved outcome.[24]

”Notwithstanding some marginal gains, the mortality and morbidity of SHIs remain unacceptably high. Most neurological centers, especially those interested in Neurotraumatology, continue to report a mortality of 30–50% and even more for patients admitted with GCS<8 even now.[25],[26],[27]

”Despite promising pre-clinical data, most trials that have been performed in recent years have failed to demonstrate any significant improvement in the outcome.”[28]

NINDS Workshop involving virtually who is of Neurotrauma research acknowledged, “The lack of clinical benefits for any of these therapeutic measures either singly or in combination.” The measures included the use of corticosteroid, barbiturates, ICP monitoring, hyperventilation, hypothermia.

”Despite claims to the contrary, no clear decrease in traumatic brain injuries (TBI)-related mortality, or an improvement in the overall outcome has been observed over the past two decades.[29] Reviewing progress in the management of severe head injury between 1960 and 1995, I came to the conclusion that, “In spite of the innumerable clinical, pathological and experimental studies the ideal management of TBI remains an elusive goal.”

Furthermore, “In this era of evidence-based medicine, most reports on therapy of these patients fail to stand up to the rigours of the scientific scrutiny. Controlled randomized or double-blind trials are conspicuous by their absence.”[30]

Steroids (19RCTs) sample size 10,008 provides strong evidence that using steroids in all patients with TBI is harmful.

Hypothermia: one robust RCT showed worse outcome in patients treated with hypothermia titrated to ICP control.

Surgery: Three robust RCTs (Decompressive Craniectomy) conflicting findings (DECRA Trial), (STITCH trial-closed prematurely) and RESCUE ICP trial.[31],[32],[33]

”Despite the considerable investment of resources and efforts in producing 191 completed RCTs, very little translatable evidence has been generated”.[34]

The results of a systematic review of TBI mortality over the past 150 years suggested that improvements in the clinical management of severe TBI have reduced case fatality rates by more than 50%. However, case fatality rates appeared to have stagnated over the past 25 years.

Stein et al: J Neurotrauma 2010 confirmed by Rosenfield et al. Lancet 2012.[34],[35],[36]

Moderate to severe brain injury (TBI) remains a major global challenge, with rising incidence, unchanging, mortality and lifelong impairment (Based on 191 RTs, enrolled 35, 340 participants).[37]

Seizures prophylaxis: Increasing trends to move away from phenytoin to newer agents (no idea of indications, duration).

This is not to say that there have not been any gains in overall care and outcome of the unfortunate victims of head trauma during those years. The introduction of ambulances fully equipped and staffed hospitals; primary care by a neurosurgical team on arrival there have proved beneficial in reducing mortality and morbidity.


  Therapy Based on Knowledge Derived from Molecular Biology Investigations Top


Based on recent knowledge gained from investigations on experimental models of head injury using molecular biology techniques, raised hopes for improving the outcome of treatment of brain injuries.[38],[39],[40],[41]

”Attempts to investigate the molecular basis of the patho-physiology revealed the insult caused by excitotoxic substances, free radicals, and other secondary metabolites of tissue damage released following the original insult” [Figure 3].
Figure 3: Molecular basis of Traumatic brain injury

Click here to view


”Therapeutics agents targeted to counter these, found to be useful in experimental animal models of head injury have not proved their utility in human beings.”[22]

To date, no clinical data are available, but more data are needed for rigorous documentation of an equivocal effect of therapeutic intervention in experimental studies before human studies will be appropriate. We believe that clinical application or manipulation of oxygen free radical scavengers will have a major role in a powerful therapeutic strategy for brain injury and brain edema in the near future.

There is an urgent need to investigate the causes of failure of neuroprotective therapies in improving the outcome of SHI. I am not aware of any ongoing experimental studies on a hypothesis based prospective clinical studies or protocol-based multi-centric therapeutic trials ongoing in the country. Yet we have today adequate expertise and facilities to undertake such studies. These may not only solve some specific problems of relevance to our country but lead to international standard studies.

To the best of the authors' knowledge so far, no reliable information is available on the beneficial role of therapy based on this knowledge.[42],[43]


  Vascular Changes Following Head Injury Top


There has been enough pathological and clinical evidence to indicate the high incidence of cerebral circulatory abnormalities associated with a severe head injury. These include cerebral ischemia, focal vascular spasm, abnormality of cerebral perfusion.[44],[45],[46],[47],[48],[49] Notwithstanding this useful information of the pathogenesis of secondary brain damage following injury, no doubt an important factor influencing the outcome has not yet led to improved therapeutic strategy.


  Neuroinflammation Following Traumatic Brain Injury Top


It is now common knowledge that neuroinflammation is a common denominator of diverse neurological diseases not only of infective origin but even others like trauma, ischemia, tumors, and degeneration. It is not just a response to the basic insult, but in many instances, it is responsible for augmenting and perpetuating the disease.[50],[51],[52],[53] In addition to its contribution to the pathology in the acute phase, it is now established that inflammation and white matter degeneration persist for years after a single brain injury.[54],[55] The possible role of anti-inflammatory drugs in ameliorating the post-traumatic pathology and consequently the outcome remain unexplored.


  The Chronic and Evolving Neurological Consequences of Tbi Top


Recognition of this new entity following TBI, which I have called the IV th Accident raises a number of unanswered questions.

- What is the incidence of Dementia, chronic traumatic encephalopathy, Parkinson's disease, late stroke following mild, moderate, severe; single or multiple TBI?

- What is its patho-physiology?

- Is it only secondary to persistent inflammation?

- Will prophylactic use of anti-inflammatory prevent their evolution?


  Post-Traumatic Epilepsy Top


- One of the most well-known and studied entity, developing as a consequence of TBI is post-traumatic epilepsy. Notwithstanding nearly a century of knowledge about this entity, there is still no consensus about:

- Its precise pathogenesis

- The indications for prophylactic use of anti-epileptic use of anti-epileptic drugs, which one for how-long?

Surgery for intracranial haematomas

The traditional multiple burr-hole explorations for diagnosis and management of post-traumatic hematomas, particularly the acute subdural, was already challenged in the 1960s.[9] The same study pointed out that the thin layer of subdural blood associated with brain contusions or intracerebral haematoma was in itself innocuous. Its drainage through burr-holes did not provide relief unless the associated parenchymatous lesion was attended to. Over the years, we confirmed this observation and outlined its surgical management. Commonly the associated parenchymatous lesion was in the temporal lobe. We advocated the removal of the contused lacerated area and the associated intracerebral haematoma along with anterior temporal lobectomy as the treatment of choice.[45] This reduced the mortality of the so-called acute subdural hematoma and the associated parenchymatous lesion to around 40%. In addition, it virtually avoided the need for decompressive craniectomy.[56]

Decompressive craniectomy

Initially advocated by Ransohoff et al. in 1971[57] and Morantz et al. (1973),[58] decompressive craniectomy for management of medically unresponsive raised intracranial pressure associated with a SHI was virtually given up as a reliable therapy. It was witnessed a revival in recent years and has been a subject of several multicentric trials.

  • The DECRA (Decompressive Craniectomy Trial, 2011)[31]
  • The RESCUEicp (Randomized Evaluation of Surgery with Craniectomy for uncontrollable Elevation of Intracranial pressure trial, 2016)[33]
  • The STITCH (Trauma): Surgical Trial in Traumatic Intracranial Haemorrhage 2015[32]
  • CHIRAG (Collaborative Head Injury and Guidelines Adherence and Outcomes Study) 2016[59]
  • CENTER-TBI (Comparative Effectiveness Research): Collaborative European Neuro Trauma Effectiveness Research in TBI 2015.[60]



  Summarizing Top


Currently, the most debated question regarding surgery relates to decompressive craniectomy, because of the conflicting results of all the existing trials. International guidelines for surgical treatment are not supported by strong evidence. There are considerable uncertainty and debate about which subgroups of patients might benefit most from some types of surgery and the optimum timing of surgery.[34]

  • Steroids (19RCTs) sample size 10,008 – provides strong evidence that using steroids in all comers with TBI is harmful
  • Hypothermia one robust RCT showed worse outcome in patients treated with hypothermia titrated to ICP control [61]
  • Surgery 3 robust RCTs (Decompressive Craniectomy) conflicting findings (DECRA trial), (STITCH trial-closed prematurely)
  • ”Despite the considerable investment of resources and efforts in producing 191 completed RCTs, very little translatable evidence has been generated”.[34]



  The Big Question Still Remains Top


  • This is not to say that there have not been any gains in overall care and outcome of the unfortunate victims of head trauma during these years. The introduction of ambulances, fully equipped for prompt resuscitation at the site of accident; quick, medically supervised transport to fully equipped and staffed hospitals; primary care by the neurosurgical team on arrival there have proved to reduce mortality and morbidity
  • Similarly, prompt diagnosis of the extent and nature of intracranial pathology using CT Scan has been a major gain Notwithstanding all this, the important question remains, “Where do we go from here?”—Tandon 1994
  • Although efforts to develop evidence-based guidelines for routine use in the ICU are a step in the right direction, this one-size-fits-all approach ignores the complex clinical and mechanistic heterogeneity of TBI—Stocchetti et al. 2017.



  Where Do We Go from Here? Top


While the currently ongoing international studies may reveal new evidence to provide better guidelines, like a true detective, is it time to go back to the tell-table evidence provided by pathological studies? Relook at the precious pathology archive of Prof Hume Adams and additional material obtained from the autopsies of the unfortunate failures of the current therapies.


  Conclusion Top


On the basis of personal experience with management of SHI and extensive review of the literature, it is obvious that in spite of revived interest on the subject there still remain a large number of unsolved problems. This presentation has highlighted only some of these. While lots need to learn about the molecular basis of the pathology, the pathogenesis of associate vascular disturbances and brain edema the possible role of genetic factors and the reason for the failure of therapeutic leads obtained from animal experiments in clinical practice.

To date, no clinical data are available, but more data are needed for rigorous documentation of an unequivocal effect of therapeutic intervention in experimental studies before human studies will be appropriate. We believe that clinical application or manipulation of oxygen free radical scavengers will have a major role in a powerful therapeutic strategy for brain injury and brain edema in the near future.

However, ultimately the most important question remains. The biggest unsolved problem of brain trauma; Is why in spite of all researches, Basic and Clinical, there has been no/little improvement in the morbidity and mortality following “Severe Head Injury”?

”Notwithstanding recent advances in 'aggressive' management of severely head-injured patients, the overall mortality and morbidity remain unacceptably high.” The results of a systematic review of TBI mortality over the past 150 years suggested that improvements in the clinical management of severe TBI have reduced case fatality rates by more than 50%.

However, case fatality rates appeared to have stagnated over the past 25 years.

Acknowledgements

I wish to record my thanks to the organizers of the ANTC 2018 for giving me this opportunity to pay my tributes to Sir Graham Teasdale, an old friend and one of the leaders of Neurotraumatology research. Special thanks are due to Professor Deepak Gupta for providing me copies of some of the recent literature on the subject.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-4.  Back to cited text no. 1
    
2.
Teasdale GM, Braakman R, Cohadon F, Dearden M, Iannotti F, Karimi A, et al. The European brain injury consortium. Nemo solus satis sapit: Nobody knows enough alone. Acta Neurochir (Wien) 1997;139:797-803.  Back to cited text no. 2
    
3.
Teasdale G, Mass A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow coma scale at 40 years standing the test of time. Lancet Neurol 2014;13:844-54.  Back to cited text no. 3
    
4.
Kristiansen K. Neurological Investigations of Patients with Acute Injuries of Head. Oslo: Skrifter utgav Det Norske Videnskaps Akademi; 1949.  Back to cited text no. 4
    
5.
Munro D. Cranio-Cerebral Injuries, Their Diagnosis and Treatment. Oxford University Press; Oxford, England, UK. 1938.  Back to cited text no. 5
    
6.
Brock S. Injuries of the Skull, Brain and Spinal Cord. Baltimore: The Williams & Wlkims Company; 1943.  Back to cited text no. 6
    
7.
Rowbotham GF. Acute Injuries of the Head: their Diagnosis, Treatment, Complications and Sequelae. 4th ed.. Baltimore: Williams & Wilkins; 1964.  Back to cited text no. 7
    
8.
Gurdjian ES, Webster JE. Head Injuries: Mechanisms, Diagnosis and Management. Boston: Little Brown & Company; 1958.  Back to cited text no. 8
    
9.
Kristiansen K, Tandon PN. Diagnosis and surgical treatment of severe craniocerebral injuries. J Oslo City Hosp 1960;10:107.  Back to cited text no. 9
    
10.
Jennett B, Teasdale G, Galbraith S, Pickard J, Grant H, Braakman R, et al. Severe head injury in three countries. J Neurol Neurosurg Psychiat 1977;40:291-5.  Back to cited text no. 10
    
11.
Ramamurthi B. Acute Subdural Haematoma. In: Vinken PJ, Bruyn GM, editors. Handbook of Clinical Neurology. Amsterdam: North-Holland Publishing Company; 1976. p. 275.  Back to cited text no. 11
    
12.
Fell DA, Fitzgerald s, Moiel RH, Caram P. Acute subdural haemtaoma. Review of 144 cases. J Neurosurg 1975;42:37-42.  Back to cited text no. 12
    
13.
Mc Laurin RL, Tutor FT. Acute subdural haematoma. Review of ninety cases. J Neurosurg 1961;18:61-7.  Back to cited text no. 13
    
14.
De Vet AC. Traumatic intracerebral haematoma. In: Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Vol. 24. Amsterdam: North Holland Publishing Company; 1976. p. 351-68.  Back to cited text no. 14
    
15.
Langfitt WT. Measuring the outcome from head injury. J Neurosurg 1978;48:673-8.  Back to cited text no. 15
    
16.
Langfitt TW, Gennarelli TA, Obrist WD, Bruce DA, Zimmerman RA. Prospects for the future in the diagnosis and management of head injury: Pathophysiology, brain imaging, and population-based studies. Clin Neurosurg 1982;29:353-76.  Back to cited text no. 16
    
17.
Gordon E. Controlled respiration in the management of patients with traumatic brain injury. Acta Anaesth Scandinav 1971;15:193-208.  Back to cited text no. 17
    
18.
Marshall LE, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injury. Part 1. J Neurosurg 1979;50:20-5.  Back to cited text no. 18
    
19.
Marshall LE, Smith RW, Shapiro HM. The outcome of aggressive treatment of severe head injury. Part II. Acute and chronic barbiturate administration in management of head injury. J. Neurosurg 1979;50:26-30.  Back to cited text no. 19
    
20.
Papo I, Carusell. G. Longterm ICP monitoring in comatose patients suffering from head injury. A critical survey. Acta Neurochirung 1977;39:187-200.  Back to cited text no. 20
    
21.
Colohan AR, Alves WM, Gross CR, Torner JC, Mehta VS, Tandon PN, et al. Head injury mortality in two centers with different emergency medical services and intensive care. J Neurosurg 1989;71:202-7.  Back to cited text no. 21
    
22.
Tandon PN. Management of head injury: Fads, fashion and facts. Neurol India 1986;34:1-30.  Back to cited text no. 22
    
23.
Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-4.  Back to cited text no. 23
    
24.
Braakman R, Gelpke GJ, Habbema JDF, Torner JC, Mehta VS, Tandon PN, et al. Systematic selection of prognostic features in patients with severe head injury. Neurosurgery 1980;6:362-70.  Back to cited text no. 24
    
25.
Raju TNK, Vidyasagar D, Torres C, Grundy D, Bennett EJ. Intubation and anesthesia in infants and anesthesia in Infants. J Pediatr 1980;96:860-2.  Back to cited text no. 25
    
26.
Dunn IF, Ellegala DB, Kim DH, Litvack ZN; Brigham and Women's Hospital Neurosurgery Group. Neuromonitoring in neurological critical care. Neurocrit Care 2006;4:83-92.  Back to cited text no. 26
    
27.
Tandon PN. Unfulfilled hopes in the management of severe head injuries. Neurotrauma Con 2008.  Back to cited text no. 27
    
28.
Narayan RK. The clinical trials in head injury study group. J Neurotrauma 2002;19:503-56.  Back to cited text no. 28
    
29.
Roozenbeck B, Mass AI, Menon DK. Changing patterns in epidemiology of traumatic brain injury. Nat Rev Neurol 2013;9:231-6.  Back to cited text no. 29
    
30.
Tandon PN. Head injury management: Future trends. In: Ramamurthi B, Tendon PN, Churchill BI, editors. Textbook of Neurosurgery. Livingstone Pvt Ltd; 1996. p. 377-80.  Back to cited text no. 30
    
31.
Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D'Urso P, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364:1493-502.  Back to cited text no. 31
    
32.
Mendelow AD, Gregson BA, Rowan EN, Francis R, McColl E, McNamee P, et al. Early surgery versus initial conservative treatment in patients with traumatic intracerebral hemorrhage (STITCH [Trauma]): The first randomized trial. J Neurotrauma 2015;32:1312-23.  Back to cited text no. 32
    
33.
Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 2016;375:1119-30.  Back to cited text no. 33
    
34.
Mans AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. Traumatic brain injury: Integrated approaches to improve prevention, clinical care and research. Lancet Neurol 2017;16:987-1048.  Back to cited text no. 34
    
35.
Stein SC, Georgoff P, Meghan S, Mizra K, Sonnad SS. 150 years of treating severe traumatic brain injury: A systematic review of progress in mortality. J Neurotrauma 2010;27:1343-53.  Back to cited text no. 35
    
36.
Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, Gruen RL. Early management of severe traumatic brain injury. Lancet 2012;380:1088-98.  Back to cited text no. 36
    
37.
Bragge P, Synnot A, Maas AI, Menon DK, Cooper DJ, Rosenfeld JV, et al. A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury. J Neurotrauma 2016;33:1461-78.  Back to cited text no. 37
    
38.
Choi, DW. Excitotoxic cell death. J Neurobiol 1992;23:1261-76.  Back to cited text no. 38
    
39.
Bullock R. Strategies for neuroprotecyion with glutamate antagonists. Extrapolating from evidence taken from first stroke and head injury studies. Ann New York Acad Sci 1995;765:272-8.  Back to cited text no. 39
    
40.
Faden AL, Demediiuk P, panter SS, Vink R. The role of excitatory aminoacids and NDA receptors in traumatic brain injury. Science 1989;244:798-800.  Back to cited text no. 40
    
41.
Dugon LL, Choi DW. Excitotoxicity, free radicals and cell membrane changes. Ann Neurol 1994;35:517-21.  Back to cited text no. 41
    
42.
Tandon PN. Head injury management: Agenda for future research. Quaterly J surgical Sci1998:67-72.  Back to cited text no. 42
    
43.
Tandon PN. Molecular aspects of head injury. In: Khosla VK, Kale VK, Sharma BS, editors. Brain Protection and Neural Trauma. New Delhi: Narosa Publishing House; 2000. p. 3-12.  Back to cited text no. 43
    
44.
Adams JH, Graham DI, Gennarelli TA. Head injury in man and experimental animals: Neuropathology. Acta Neurochir Suppl (Wien) 1983;32:15-30.  Back to cited text no. 44
    
45.
Tandon PN, Prakash B, Banerji AK. Temporal lobe lesions in head injury. Acta Neurochirung 1978;41:205-21.  Back to cited text no. 45
    
46.
Suwanwela C, Suwanwela N. Intracranial arterial narrowing and spasm in acute head injury. J Neurosurg 1972;36:314-23.  Back to cited text no. 46
    
47.
Miller JD, Bullock R, Graham DI, Chen MH, Teasdale GM. Ischaemic brain damage in a model of acute subdural haematoma. Neurosurgery 1990;27:433-9.  Back to cited text no. 47
    
48.
Muizellar JP, Schroder ML. Overview of monitoring of cerebral blood flow and metabolism after severe head injury. Canadian J Neurol Sci 1994;21:56-61.  Back to cited text no. 48
    
49.
Weber, Grolimund, Seiler RW. Evaluation of post traumatic cerebral blood flow velocities by transcranial Doppler ultrasonography. Neurosurg 1990;27:106-12.  Back to cited text no. 49
    
50.
Tandon PN. Biology of neuroinflammation: A common denomination in brain pathologies. In: Jana N, Tandon PN, Basu A, editors. Inflammation: The common link in brain pathologies. Singapore: Springer Science and Business Media; 2016. p. 1-16.  Back to cited text no. 50
    
51.
Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc London B Bio Sci 2003;358:1669-77.  Back to cited text no. 51
    
52.
Gentleman SM, Leclereq PD, Moyes L, Graham DI, Smith C, Griffin WS, et al. Long term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004;146:97-104.  Back to cited text no. 52
    
53.
Guo Z, Cupples A, Kurz A. Head injury and risk of AD in MIRAGE study. Neurology 2000;54:1316-23.  Back to cited text no. 53
    
54.
Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single brain injury. Brain 2013;136:28-42.  Back to cited text no. 54
    
55.
Plassman BL, Havlik RJ, Steffens DC, Helms MJ. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 2000;55:1158-66.  Back to cited text no. 55
    
56.
Tandon PN. Acute subdural hematoma: A reappraisal. Neurol India 2001;49:3-10.  Back to cited text no. 56
[PUBMED]  [Full text]  
57.
Ransohoff J, Benjamin MV, Gage EL, Epstein F. Hemicraniectomy in the management of acute subdural haematoma. J Neurosurg 1971;34:70-6.  Back to cited text no. 57
    
58.
Morantz RE, Abad RA, George AE, Epstein F. Hemicraniectomy for acute extracerebral haematoma; an initial analysis of clinical and radiographic findings. J Neurosurg 1973;39:622-8.  Back to cited text no. 58
    
59.
Gupta D, Sharma D, Kannan N, Prapruettham S, Mock C, Wang J, et al. Guideline adherence and outcomes in severe adult traumatic brain injury for the CHIRAG (Collaborative Head Injury and Guidelines) Study. World Neurosurg 2016;89:169-79.  Back to cited text no. 59
    
60.
Maas AI, Menon DK, Steyerberg EW, Citerio G, Lecky F, Manley GT, et al. Collaborative European neuro trauma effectiveness research in traumatic brain injury (CENTER-TBI): A prospective longitudinal observational study. Neurosurgery 2015;76:67-80.  Back to cited text no. 60
    
61.
Cooper DJ, Nichol AD, Bailey M, Bernard S, Cameron PA, Pili-Floury S, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: The POLAR randomized clinical trial. JAMA 2018;320:2211-20.  Back to cited text no. 61
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow